Learn the Latest In CAR T with ASTCT Webinars

Reviewing Real-World Use of Beti-Cel in Transfusion-Dependent β-Thalassemia

This case report and literature review emphasize that ICI-IA should not be ruled out based on the presence of synovial fluid with elevated WBC with a neutrophil predominance. Early steroid use should be considered.

Therapies like betibeglogene autotemcel have been “life-changing” for patients with β-thalassemia, according to Nora M. Gibson, MD, MSCE.

Nora M. Gibson, MD, MSCE;Taha Al-Juhaishi, MD

Workplace Burnout Among Oncologists Has Risen: What Can Be Done?

Therapies such as betibeglogene autotemcel have been “life-changing” for patients with β-thalassemia, according to Nora M. Gibson, MD, MSCE.

Tim Cortese

Fostering the Future of Psychosocial Care With World Psycho-Oncology Day

Results from a recent survey showed that 20% of oncologists planned to reduce their hours in the next 12 months, as workplace burnout among them has increased.

Cristiane Decat Bergerot, PhD

April 14th 2025

Organ Preservation Noted With Neoadjuvant Dostarlimab in dMMR Tumors

Integrating psychosocial care into cancer care allows patients to receive emotional support, counseling, and coping strategies to help navigate treatment.

Caroline Seymour

April 29th 2025

Health Care Professional Research Highlights Barriers to Clinical Trial Diversity

A phase 2 study found a complete clinical response of 82% with neoadjuvant dostarlimab in dMMR solid tumors.

Tim Cortese

April 28th 2025

Synovial Fluid in Checkpoint Inhibitor–Induced Inflammatory Arthritis

Related Content

Mary Katherine L. Anderson, MD;James P. Fagerland, MD;Samantha Kohn, MD, MS;Amy C. Cannella, MD;Benjamin A. Teply, MD

May 16th 2025

Reviewing Real-World Use of Beti-Cel in Transfusion-Dependent β-Thalassemia

Nora M. Gibson, MD, MSCE;Taha Al-Juhaishi, MD

Workplace Burnout Among Oncologists Has Risen: What Can Be Done?

Therapies such as betibeglogene autotemcel have been “life-changing” for patients with β-thalassemia, according to Nora M. Gibson, MD, MSCE.

Tim Cortese

Fostering the Future of Psychosocial Care With World Psycho-Oncology Day

Results from a recent survey showed that 20% of oncologists planned to reduce their hours in the next 12 months, as workplace burnout among them has increased.

Cristiane Decat Bergerot, PhD

April 14th 2025

Organ Preservation Noted With Neoadjuvant Dostarlimab in dMMR Tumors

Integrating psychosocial care into cancer care allows patients to receive emotional support, counseling, and coping strategies to help navigate treatment.

Caroline Seymour

April 29th 2025